Since 1999, BioAutomation has served the biotechnology industry with automation solutions to assist in research and development.
FDA warns that poor metabolizers of (PLAVIX TM) are at increased risk for adverse cardiovascular events!
Inclusion of 99% of the most relevant genetic markers of ADME/T (absorption, distribution, metabolism, excretion, and toxicity)
Diagnostic gene testing is used to confirm a specific diagnosis in symptomatic patients.
Caloric intake; weight loss, physical activity, and weight management; day-to-day carbohydrate consistency; nutritional content; and meal timing.